To gain insight on how OL and myelin may improve neuronal deficits associated with AD, we have generated a novel mouse model (AD/cKO) by crossing the AppNL-G-F mouse which carries three human AD mutations in the mouse App gene with the FusOLcKO, which has thicker myelin associated with greater cholesterol biosynthesis. The gene discussed is APP; the disease is Alzheimer disease.